Gueven, Nuri

< Back to all Authors
Group by: Item type | Date
Number of items: 4.

24 January 2020

Timpani, Cara ORCID: 0000-0003-4567-4319, Goodman, Craig ORCID: 0000-0002-5874-7743, Stathis, Christos ORCID: 0000-0003-0064-9523, White, Jason D, Mamchaoui, Kamel, Butler-Browne, Gillian, Gueven, Nuri, Hayes, Alan ORCID: 0000-0003-1398-3694 and Rybalka, Emma ORCID: 0000-0002-4854-0036 (2020) Adenylosuccinic acid therapy ameliorates murine Duchenne Muscular Dystrophy. Scientific Reports, 10. ISSN 2045-2322

13 October 2020

Kourakis, Stephanie ORCID: 0000-0001-5683-9989, Timpani, Cara ORCID: 0000-0003-4567-4319, de Haan, Judy B, Gueven, Nuri, Fischer, Dirk and Rybalka, Emma ORCID: 0000-0002-4854-0036 (2020) Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility? Pharmaceuticals, 13 (10). ISSN 1424-8247

1 January 2021

Kourakis, Stephanie ORCID: 0000-0001-5683-9989, Timpani, Cara ORCID: 0000-0003-4567-4319, de Haan, Judy B, Gueven, Nuri, Fischer, Dirk and Rybalka, Emma ORCID: 0000-0002-4854-0036 (2021) Targeting Nrf2 for the treatment of Duchenne Muscular Dystrophy. Redox Biology, 38. ISSN 2213-2317

1 December 2021

Kourakis, S, Timpani, Cara ORCID: 0000-0003-4567-4319, Campelj, Dean G, Hafner, P, Gueven, Nuri, Fischer, Dirk and Rybalka, Emma ORCID: 0000-0002-4854-0036 (2021) Standard of care versus new-wave corticosteroids in the treatment of Duchenne muscular dystrophy: Can we do better? Orphanet Journal of Rare Diseases, 16 (1). ISSN 1750-1172 (In Press)